Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2

J Park1, I Kim, Y J Oh

  • 1Cell Biology Laboratory, Hanhyo Institute of Technology, 461-6, Jeonmin-dong, Yuseong-ku, Taejon 305-390, Korea.

Insights

Bcl-2 protein prevents cell death by inhibiting the c-Jun N-terminal kinase (JNK) signaling pathway. This discovery offers new insights into the anti-apoptotic mechanisms of Bcl-2.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Neuroscience

Background:

  • Bcl-2 is a key intracellular protein that inhibits apoptosis.
  • The precise mechanisms underlying Bcl-2's anti-apoptotic function remain incompletely understood.
  • Understanding Bcl-2's role is crucial for developing therapies targeting cell death.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Bcl-2 exerts its cell death-protective effects.
  • To investigate the involvement of the c-Jun N-terminal kinase (JNK) signaling pathway in Bcl-2's function.
  • To determine if Bcl-2 interferes with specific components of the JNK pathway.

Main Methods:

  • Utilized N18TG neuroglioma cells as a model system.
  • Exposed cells to various apoptotic stimuli including etoposide, staurosporine, anisomycin, and UV irradiation.
  • Assessed cell death, JNK activation, and MEKK1 stimulation in the presence and absence of Bcl-2.
  • Investigated the effect of JNK overexpression on Bcl-2's protective function.

Main Results:

  • Bcl-2 effectively suppressed apoptosis induced by diverse apoptotic stresses.
  • Bcl-2 disrupted the activation of the JNK signaling cascade in response to these stresses.
  • Bcl-2 inhibited the etoposide-induced activation of MEKK1, a JNK pathway kinase.
  • Overexpression of JNK counteracted the cell death-suppressing activity of Bcl-2.

Conclusions:

  • The findings strongly suggest that Bcl-2's anti-apoptotic activity is mediated, at least in part, by the suppression of the JNK signaling pathway.
  • Disruption of JNK activation is a critical component of Bcl-2's mechanism of action.
  • This study provides a mechanistic link between Bcl-2 and the JNK pathway, relevant to cell death regulation.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...